// App-Quantinova.ai

BSH19‐PO‐168 : Can long acting factors go a long way; a real‐life single centre retrospective study of Haemophilia B patients who have switched to extended half‐life factor IX

Researchers

Presenter

  • A. Rampotas

Principal Investigators

  • S. Raza-Burton

  • S. Taylor

  • A. Wilkinson

  • M. Desborough

  • G. Hall

  • S. Shapiro

  • N. Curry

Medical Centers

  • Oxford Haemophilia and Thrombosis Centre

  • Children's Haematology and Oncology, Oxford University Hospitals NHS Foundation Trust, NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Hemophilia

  • Venous thrombosis

Biomarkers

  • Human albumin

Drug/Treatment

  • Alprolix Intravenous

  • Idelvion Intravenous

Outcome

  • N/A

Study Design

  • Pharmacokinetics

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved